Andrew has over 15 years of experience in biotechnology, pharmaceuticals, diagnostics, and other healthcare sectors. His team specializes in growth strategy projects pertaining to cutting-edge medical technologies. Since 2012, his team has conducted over 100 projects for executives in the C suite, commercial franchises, corporate development, and R&D, and spanning nearly every therapeutic area undergoing innovation.  In this episode, he gives an in-depth view of the biotech industry. Andrew can be reached through LinkedIn or you can email him at Andrew@headlandstrategy.com. And you can listen to more from Andrew on Episode 355. Key points include: 01:09:  A quick explanation of biotech, agricultural biotech, and industrial biotech 08:09: The difference between pharma and biotech 12:28: Drugs that fall into the biotech category 18:45: Differences in delivery methodologies between small molecule and more complex molecules 24:31: The different roles and functions at biotech and pharma companies Unleashed is produced by Umbrex, which has a mission of connecting independent management consultants with one another, creating opportunities for members to meet, build relationships, and share lessons learned. Learn more at www.umbrex.com.